The Permanent Senate Commission for the Investigation of Health Hazards of Chemical Compounds in the Work Area of the DFG has now published the English version of its latest research-based recommendations on the risk assessment of substances used at the workplace.
Boston Scientific acquires Axonics, urology company, for $3.7 billion
Boston Scientific said it will buy Axonics, a device company treating urinary and bowel disorders, on Monday. The deal is worth $3.7 billion. It’s the